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Clinical stability occurs when cancers reach a state where the disease neither advances nor regresses. 
Tumors can remain in this state for multiple years before progressing to more aggressive phenotypes. The 
mechanisms for maintaining a stable state and the factors that contribute to tumor activation are poorly 
understood. We hypothesized that an implantable biomaterial scaffold would be able to isolate a population of 
stable tumor cells that could then be used to study the transition to an aggressive phenotype. In this work we 
developed a tunable and highly controlled, porous acrylamide scaffold and subcutaneously implanted them in 
immunodeficient (NSG) mice. Prior to implantation scaffolds were seeded with a variety of different cell types. 
Specifically, human bone marrow stromal cells were supplemented with mouse stromal cells genetically 
engineered to express human cytokines to promote the generation of different tissue microenvironments in the 
scaffolds. After implantation the mice received an orthotopic injection of either human breast or prostate cancer 
cells. The tumors were allowed to generate metastases to the scaffolds and other tissues. Scaffolds were 
transplanted to non-tumor bearing mice once the tumor burden became exhaustive to the host to allow for 
further study of the microenvironment. The role of immune cells on the tumor microenvironment was also 
explored. Human peripheral blood mononuclear cells were isolated from donors and injected intravenously 
prior to transplantation. Bioluminescent imaging was used to capture tumor growth in vivo over a ten week 
period. The scaffolds were analyzed via immunohistochemical staining on thinly sectioned tissue and intact 
tissue cleared samples to characterize the tissue microenvironment and its effect on tumor progression. Our 
work has demonstrated the application of implantable tissue engineered microenvironments to study the 
phenomena of tumor stability in vivo and has uncovered some potentially important factors that drive the 
transition from stable to aggressive tumors.  
 
Contact: 
Ryan Carpenter 
Lee Lab 
Chemical Engineering 
University of Massachusetts Amherst 
rcarpenter@umass.edu 
 
 
